Relación precio/ingresos (P/S)
desde 2005
Cálculo
Amgen Inc., P/S, tendencias a largo plazocálculo
| P/S | = | Precio de la acción1, 2, 3 | ÷ | Ventas por acción1 | Ventas por acción1 | = | Venta de productos1 (en millones) |
÷ | Número de acciones ordinarias en circulación2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 feb 2025 | 4.88 | = | 291.16 | ÷ | 59.62 | 59.62 | = | 32,026 | ÷ | 537,204,943 | |
| 14 feb 2024 | 5.78 | = | 290.07 | ÷ | 50.21 | 50.21 | = | 26,910 | ÷ | 535,918,901 | |
| 9 feb 2023 | 5.17 | = | 240.00 | ÷ | 46.45 | 46.45 | = | 24,801 | ÷ | 533,976,238 | |
| 16 feb 2022 | 5.10 | = | 222.66 | ÷ | 43.62 | 43.62 | = | 24,297 | ÷ | 557,029,370 | |
| 9 feb 2021 | 5.64 | = | 236.65 | ÷ | 41.97 | 41.97 | = | 24,240 | ÷ | 577,566,383 | |
| 12 feb 2020 | 6.03 | = | 227.00 | ÷ | 37.65 | 37.65 | = | 22,204 | ÷ | 589,806,819 | |
| 13 feb 2019 | 5.22 | = | 188.98 | ÷ | 36.21 | 36.21 | = | 22,533 | ÷ | 622,278,034 | |
| 13 feb 2018 | 5.82 | = | 175.94 | ÷ | 30.25 | 30.25 | = | 21,795 | ÷ | 720,562,246 | |
| 14 feb 2017 | 5.65 | = | 168.05 | ÷ | 29.73 | 29.73 | = | 21,892 | ÷ | 736,452,791 | |
| 16 feb 2016 | 5.28 | = | 147.15 | ÷ | 27.85 | 27.85 | = | 20,944 | ÷ | 752,091,038 | |
| 19 feb 2015 | 6.13 | = | 156.05 | ÷ | 25.47 | 25.47 | = | 19,327 | ÷ | 758,861,306 | |
| 24 feb 2014 | 5.22 | = | 125.79 | ÷ | 24.10 | 24.10 | = | 18,192 | ÷ | 755,007,290 | |
| 27 feb 2013 | 4.09 | = | 91.03 | ÷ | 22.23 | 22.23 | = | 16,639 | ÷ | 748,430,018 | |
| 29 feb 2012 | 3.52 | = | 68.01 | ÷ | 19.33 | 19.33 | = | 15,295 | ÷ | 791,432,134 | |
| 25 feb 2011 | 3.32 | = | 52.26 | ÷ | 15.72 | 15.72 | = | 14,660 | ÷ | 932,452,902 | |
| 1 mar 2010 | 3.88 | = | 56.90 | ÷ | 14.65 | 14.65 | = | 14,351 | ÷ | 979,301,627 | |
| 27 feb 2009 | 3.44 | = | 48.93 | ÷ | 14.20 | 14.20 | = | 14,687 | ÷ | 1,033,964,089 | |
| 28 feb 2008 | 3.46 | = | 45.53 | ÷ | 13.16 | 13.16 | = | 14,311 | ÷ | 1,087,627,536 | |
| 28 feb 2007 | 5.41 | = | 64.26 | ÷ | 11.87 | 11.87 | = | 13,858 | ÷ | 1,167,458,942 | |
| 10 mar 2006 | 7.24 | = | 73.49 | ÷ | 10.15 | 10.15 | = | 12,022 | ÷ | 1,184,633,787 |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
1 US$
2 Datos ajustados por divisiones y dividendos de acciones.
3 Precio de cierre a la fecha de presentación del informe anual de Amgen Inc.
Comparación con la competencia
Amgen Inc., P/S, tendencias a largo plazo, comparación con los competidores
| Amgen Inc. | AbbVie Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 feb 2025 | 4.88 | 6.04 | 2.36 | 6.23 | 18.25 | 4.98 | 4.26 | 3.60 | 2.32 | 5.52 | 4.73 | 10.78 |
| 14 feb 2024 | 5.78 | 5.72 | 2.19 | 7.76 | 20.77 | 3.40 | 4.43 | 5.43 | 2.61 | 7.84 | 4.99 | 11.16 |
| 9 feb 2023 | 5.17 | 4.61 | 3.29 | 5.79 | 10.96 | 3.86 | 4.34 | 4.71 | 2.35 | 7.01 | 4.73 | 8.56 |
| 16 feb 2022 | 5.10 | 4.53 | 3.16 | 6.37 | 8.01 | 2.85 | 4.66 | 3.96 | 3.15 | 4.20 | 5.39 | 8.21 |
| 9 feb 2021 | 5.64 | 4.05 | 3.16 | 7.01 | 8.06 | 3.24 | 5.15 | 3.93 | 4.42 | 6.24 | 5.52 | 8.82 |
| 12 feb 2020 | 6.03 | 4.22 | 5.52 | 6.29 | 6.03 | 4.00 | 4.79 | 4.33 | 3.66 | 5.34 | 4.83 | 14.95 |
| 13 feb 2019 | 5.22 | 3.58 | 3.67 | 3.97 | 5.15 | 3.84 | 4.45 | 4.92 | 4.49 | 6.62 | 4.24 | 15.54 |
| 13 feb 2018 | 5.82 | 6.67 | 5.02 | 3.70 | 3.71 | 4.10 | 4.56 | 3.68 | 4.05 | 5.92 | 4.01 | 16.42 |
| 14 feb 2017 | 5.65 | 3.84 | 4.72 | 3.48 | 4.18 | 3.08 | 4.62 | 4.54 | 3.84 | 7.86 | 3.37 | 12.51 |
| 16 feb 2016 | 5.28 | 3.83 | 6.07 | 2.91 | 4.02 | 3.80 | 4.13 | 3.56 | 3.76 | 9.38 | 3.05 | 20.38 |
| 19 feb 2015 | 6.13 | 4.90 | 6.28 | 3.09 | 4.03 | 6.36 | 3.77 | 3.93 | 4.24 | 14.62 | 3.06 | 47.41 |
| 24 feb 2014 | 5.22 | 4.31 | 5.48 | 2.78 | 2.81 | 11.95 | 3.63 | 3.78 | 3.97 | 15.52 | 3.74 | 16.53 |
| 27 feb 2013 | 4.09 | 3.30 | 3.40 | 2.32 | 2.71 | 6.95 | 3.17 | 2.73 | 3.34 | 11.66 | 2.12 | 6.60 |
| 29 feb 2012 | 3.52 | — | 2.63 | 2.28 | 1.87 | 4.22 | 2.75 | 2.43 | 2.37 | 20.90 | 1.77 | 5.61 |
| 25 feb 2011 | 3.32 | — | 2.23 | 2.48 | 1.73 | 4.19 | 2.65 | 2.18 | 2.27 | 7.38 | 2.00 | 56.82 |
| 1 mar 2010 | 3.88 | — | 2.27 | 2.16 | 1.82 | 6.64 | 2.82 | 4.23 | 2.83 | 5.74 | 1.98 | 80.12 |
| 27 feb 2009 | 3.44 | — | 1.96 | 1.30 | 1.66 | 8.03 | 2.37 | 2.14 | 1.72 | 5.17 | 1.44 | 28.70 |
| 28 feb 2008 | 3.46 | — | 2.30 | 2.16 | 3.05 | 10.90 | 2.95 | 4.04 | 3.11 | 11.94 | 2.40 | 12.17 |
| 28 feb 2007 | 5.41 | — | 3.07 | 2.30 | 3.80 | 12.67 | 3.53 | 4.23 | 3.67 | 19.70 | 5.05 | 17.58 |
| 10 mar 2006 | 7.24 | — | 2.34 | 2.40 | 4.31 | 15.36 | 3.49 | 3.50 | 3.77 | 14.06 | 2.15 | 26.93 |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
Comparativa con el sector industrial: Pharmaceuticals, Biotechnology & Life Sciences
Amgen Inc., P/S, tendencias a largo plazo, en comparación con el sector industrial: pharmaceuticals, biotechnology & life sciences
| Amgen Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| 14 feb 2025 | 4.88 | 5.55 |
| 14 feb 2024 | 5.78 | 5.89 |
| 9 feb 2023 | 5.17 | 4.56 |
| 16 feb 2022 | 5.10 | 4.50 |
| 9 feb 2021 | 5.64 | 4.90 |
| 12 feb 2020 | 6.03 | 4.88 |
| 13 feb 2019 | 5.22 | 4.54 |
| 13 feb 2018 | 5.82 | 4.60 |
| 14 feb 2017 | 5.65 | 4.29 |
| 16 feb 2016 | 5.28 | 4.10 |
| 19 feb 2015 | 6.13 | 4.54 |
| 24 feb 2014 | 5.22 | 4.30 |
| 27 feb 2013 | 4.09 | 3.25 |
| 29 feb 2012 | 3.52 | 2.58 |
| 25 feb 2011 | 3.32 | 2.44 |
| 1 mar 2010 | 3.88 | 3.00 |
| 27 feb 2009 | 3.44 | 2.22 |
| 28 feb 2008 | 3.46 | 3.19 |
| 28 feb 2007 | 5.41 | 3.88 |
| 10 mar 2006 | 7.24 | 3.84 |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
Comparación con la industria: Health Care
Amgen Inc., P/S, tendencias a largo plazo, en comparación con la industria: health care
| Amgen Inc. | Health Care | |
|---|---|---|
| 14 feb 2025 | 4.88 | 3.36 |
| 14 feb 2024 | 5.78 | 3.52 |
| 9 feb 2023 | 5.17 | 51,413.66 |
| 16 feb 2022 | 5.10 | 3.28 |
| 9 feb 2021 | 5.64 | 3.31 |
| 12 feb 2020 | 6.03 | 3.21 |
| 13 feb 2019 | 5.22 | 3.07 |
| 13 feb 2018 | 5.82 | 3.06 |
| 14 feb 2017 | 5.65 | 2.80 |
| 16 feb 2016 | 5.28 | 2.72 |
| 19 feb 2015 | 6.13 | 3.08 |
| 24 feb 2014 | 5.22 | 2.81 |
| 27 feb 2013 | 4.09 | 2.20 |
| 29 feb 2012 | 3.52 | 1.90 |
| 25 feb 2011 | 3.32 | 1.80 |
| 1 mar 2010 | 3.88 | 2.08 |
| 27 feb 2009 | 3.44 | 1.70 |
| 28 feb 2008 | 3.46 | 2.42 |
| 28 feb 2007 | 5.41 | 2.85 |
| 10 mar 2006 | 7.24 | 3.17 |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).